Rafia Rasu earned her Ph.D. from the University of Texas School of Public Health with a major concentration in Health Economics and Outcomes Research. Rasu completed her pharmacy degrees (BPharm and MPharm) from the University of Dhaka Bangladesh, followed by an MBA from the same institution in 2001. She joined the KU School of Pharmacy as a tenured Associate Professor of Pharmacy Practice in September 2014.
Rasu is the Director of the Kansas City Antibiotic Resistance Task Force (KART) program, supervises the outcomes research lab located at the KUMC Department of Pharmacy Practice, and serves as a researcher at the Kansas City Department of Veterans Affairs Medical Center.
Her research interests are in the areas of outcomes research, pharmacoeconomics, pharmacoepidemiology, managed care, health literacy, health services research, economic evaluation of health care interventions, and public health.
Basic components of public health, epidemiology, pharmacovigilance, prevention, and determinants of health concepts are covered by me. I equip students to apply public health and pharmacoepidemiologycal principles to assess disease surveillance and enhance population health.
- Public Health Managed Care Pharmacy Outcoems Research
My research objectives focus on the effectiveness of medical care delivery, outcomes research, and economic evaluation of health care utilization and public health. As evident from my peer reviewed publications (total 35 papers in 10 years) and projects, I have expertise and experience in mentoring graduate students and junior faculty to grow as an independent researcher. I supervise the outcomes research lab located at the KUMC Department of Pharmacy Practice, and serves as a researcher at the Kansas City Department of Veterans Affairs Medical Center. I have several ongoing interdisciplinary research projects at KU.
- Outcomes research, pharmacoeconomics, pharmacoepidemiology, managed care, health literacy, health services research, economic evaluation of health care interventions, geriatrics, and public health.
Grant reviewer of NIH and AHA
Editorial board member of Journal of Managed care Pharmacy (JMCP)
Departmental promotion and tenure portfolio review
Director Kansas City Antibiotic Resistance Task Force
Rasu, R. Olotu, B. & Hanson, M. (n.d.). Contemporary Profile of Chronic Dialysis Patients Receiving Oral P2Y12 Inhibitors: A Single Center Experience.
Sawkin, M. Deppe, S. Thelen, J. Stoner, S. Dietz, C. & Rasu, R. (2015). Health Literacy and Medication Adherence Among Patients Treated in a Free Health Clinic A Pilot Study. Health Services Research and Managerial Epidemiology, 2, 1-9. http://hme.sagepub.com/content/2/2333392815589094.full.pdf
Rasu, R. Agbor Bawa, W. Snella, K. & Warady, B. (2015). Health Literacy Impact on National Healthcare Utilization and Expenditure. International Journal of Health Policy and Management , 4(11), 747-55. http://www.ncbi.nlm.nih.gov/pubmed/26673335
Hughes, G. Aboyade, O. Hill, J. & Rasu, R. (2015). Role and Importance of Economic Evaluation of Traditional Herbal Medicine Use for Chronic Non-communicable Diseases. Comparative Effectiveness Research, 5, 49-55. DOI:10.2147/CER.S77163 https://www.dovepress.com/the-role-and-importance-of-economic-evaluation-of-traditional-herbal-m-peer-reviewed-article-CER
Rasu, R. Melton, B. & Rianon, N. (2015). Medication Reconciliation and falls during hospitalization: A Report from 2007-2014 HERON database on geriatric patients in the hospital.
Suminski, R. Heinrich, K. Wasserman, J. & Rasu, R. (2015). Perceived neighborhood size: implications for physical activity-environment research. J Phys Act Health, 12(2), 282-288. http://www.ncbi.nlm.nih.gov/pubmed/24770653
Rasu, R. Cline, S. Shaw, J. Hayes, O. Agbor-Bawa, W. & Cifaldi, M. (2014). Impact of Juvenile Idiopathic Arthritis on Parents’ Work Absences. Rheumatology, 276-286.
Pocholec, M. . (10/01/2017 - 10/31/2017). Exposure to Antiretrovirals and Risk of Chronic Kidney Disease in HIV-positive Patients with Normal Renal Function: A Single Center Cohort Study
. IDWeek. San Diego, CA
Hansen, M. Olotu, B. & Jain, N. . (10/01/2016 - 10/31/2016). Characteristics of End-Stage Renal Disease Patients on Dialysis Prescribed P2Y12 Inhibitors: A Retrospective Chart Review’. American College of Clinical Pharmacy Annual Meeting.
. Hollywood, Florida
Rasu, Rafia Sultana, (Principal), Health literacy and use of plain language to improve health communications, The Health Care Fdn of Greater KC, $54,813, Submitted 01/14/2015 . Foundation. Status: Not Funded.
Sharma, Neena, (Co-Investigator), Rasu, Rafia, Pharmacotherapy for pain management among Medicare beneficiaries: Analysis of Medicare data, University of Kansas Medical Center Frontiers Pilot Grant, $20,000, . University (KU or KUMC). Status: Proposal Submitted.
Rasu, Rafia, (Principal), Use Medicare data to measure new-onset diabetes among patients using statin therapy, $8,000, . The use of statins (including the use of high-intensity or intensive-dose statins) for primary prevention of cardiovascular disease among elderly patients without clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes is controversial. This controversy is further heightened by the 2013 release of the American College of Cardiology/American Heart Association cholesterol guidelines which shifted emphasis from ‘targeting to treatment’ levels of low-density lipoprotein cholesterol to recommending the use of appropriate levels of statin intensity to treat or prevent clinical ASCVD. Some clinicians are concerned that the 10-year ASCVD risk threshold of 7.5% adopted by the guideline is too low and may overestimate ASCVD risk among the elderly by virtue of their advanced age (Lim, 2014). In addition, no one knows how the new 2013 cholesterol guidelines might have changed statin prescribing patterns among the elderly. Thus, it is possible that some elderly population without diabetes or clinical ASCVD might be unnecessarily treated with statin therapy and thus exposed to potential risks for statin-induced diabetes (Sattar, 2010; Culver, 2012) and painful myopathies which can limit physical functioning and quality of life (Rallidis, 2012). Our preliminary results of statin use among Americans aged 18-64 years showed that intensive-dose statins users have a 52% higher diabetes risk compared to moderate-dose statin users. University (KU or KUMC). Status: Funded.
Rasu, Rafia, (Principal), Level of Health Literacy and its Impact on Prescription Medications Usage and Expenditure among VA Beneficiaries in Kansas City, $10,000, Submitted 02/01/2015 (05/01/2015 - 06/30/2017) . University (KU or KUMC). Status: Funded.